Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

More documents

Recommendations

Info

McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF. The independentcontributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?Diabetes Care 1995;18:216-9.Meade TW, Gardner MJ, Cannon P, Richardson PC. Observer variability in recording peripheralpulses. Br Heart J 1968;30:661-5.Moss SE, Klein R, Klein B. Long-term incidence of lower-extremity amputations in a diabeticpopulation. Arch Fam Med 1996;5:391-8.NADC. ANDIAB. Australian National Diabetes Information Audit and Benchmarking. Final report.National Association of Diabetes Centres; Sydney: 2000.Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report andrecommendations of an international workshop sponsored by the American Heart Association and theAmerican Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care1993;16:1199-209.Payne CB. Diabetes-related lower-limb amputations in Australia. MJA 2000;173:352-4.Pecoraro RE, Reiber GE. Classification of wounds in diabetic amputees. Wounds 1990;2:65-73. (Can'tfind)Pichert JW, Penha ML. Institutionalization of diabetes care and education programs: A tale of twocities. Diabetes Educ 1993;19:273-7.Pirart J. Degenerative diabetic complications. Is persistent hyperglycemia more dangerous than wideglycemic fluctuations? Nouv Presse Med 1978;7:4031-5.Plummer ES, Albert SG. Foot care assessment in patients with diabetes: A screening algorithm forpatient education and referral. Diabetes Educ 1995;21:47-51.Reiber GE. Epidemiology of the diabetic foot. In: Levin ME, O'Neal LW, Bowker JH. The DiabeticFoot. Mosby Year Book, St Louis. 1993;1-5.Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998;176(Suppl2A):S5-10.Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus.A case-control study. Ann Intern Med 1992;117:97-105.Reiber GE, Smith DG, Boone DA, del Aguila M, Borchers RE, Mathews D, Joseph AW, Burgess EM.Design and pilot testing of the DVA/Seattle Footwear System for diabetic patients with footinsensitivity. J Rehabil Res Dev 1997;34:1-8.Reiber GE, Smith DG, Wallace CM, Vath CA, Sullivan K, Hayes S, Yu O, Martin D, Maciejewski M.Footwear used by individuals with diabetes and a history of foot ulcer. J Rehabil Res Dev2002b;39:615-22.Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathwaysfor incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care1999;22:157-62.Shaw JE, Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabetes1997;46(Suppl 2):S58-61.Sims DS Jr, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot. Recognition and management.Phys Ther 1988;68:1887-902.112
Sugarman JR, Reiber GE, Baumgardner G, Prela CM, Lowery J. Use of the therapeutic footwearbenefit among diabetic medicare beneficiaries in three states, 1995. Diabetes Care 1998;21:777-81.Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ. Foot complications nType 2 diabetes: an Australian population-based study. Diabet Med 2003;20:105-13.Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheralsensorimotor polyneuropathy. Diabetes Care 1998;21:1749-52.Tovey FI. The manufacture of diabetic footwear. Diabet Med 1984;1:69-71.UKPDS 33. Intensive blood-glucose control with sulphonylureas or insulin compared withconventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998;352:837-53.Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with highfoot pressure: a prospective study. Diabetologia 1992;35:660-3.Young MJ, Veves A, Boulton AJ. The diabetic foot: aetiopathogenesis and management. DiabetesMetab Rev 1993a;9:109-27.Young M, Matthews C. Neuropathy screening: can we achieve our ideals? Diabetic Foot 1998;1:22-5.Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of theprevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.Diabetologia 1993b;36:150-4.113
Page 1:
National Evidence Based Guidelinesf
Page 4:
Research OfficersMs Linda SmithPodi
Page 7 and 8:
2.2 Issues for Foot Problems in Typ
Page 9:
• Aim to achieve the best possibl
Page 12 and 13:
Background - Peripheral Neuropathy
Page 14 and 15:
proportion of subjects with a durat
Page 16 and 17:
and an OR 1.1-7.8. This study also
Page 18 and 19:
Summary - Peripheral Neuropathy as
Page 20 and 21:
Section 2: Diabetes Foot ProblemsIs
Page 22 and 23:
predicting risk of amputation, 2.9
Page 24 and 25:
Summary - Peripheral Vascular Disea
Page 26 and 27:
Page 28 and 29:
Evidence - Foot Deformity and Previ
Page 30 and 31:
people with both LJM and neuropathy
Page 32 and 33:
Summary - Foot Deformity and Previo
Page 34 and 35:
Page 36 and 37:
Also in the Seattle study, 67 peopl
Page 38 and 39:
Summary - Ulcer as a Risk Factor fo
Page 40 and 41:
Page 42 and 43:
The other frequently reported metho
Page 44 and 45:
side; and 82% having the same resul
Page 46 and 47:
Evidence Table: Section 5Detection
Page 48 and 49:
Background - Clinical Detection of
Page 50 and 51:
pulse was bilaterally absent in 1.8
Page 52 and 53:
Evidence Table: Section 6AuthorClin
Page 54 and 55:
Background - Frequency of Foot Exam
Page 56 and 57:
Summary - Frequency of Foot Examina
Page 58 and 59:
Page 60 and 61:
Behaviour assessment scores, measur
Page 62 and 63: Mazzuca et al (1986) studies 532 pe
Page 64 and 65: with before the programme, after 1-
Page 66 and 67: Evidence Table: Section 8AuthorEffe
Page 68 and 69: Background - Glycaemic Control and
Page 70 and 71: In a previous Japanese randomised s
Page 72 and 73: Evidence Table: Section 9AuthorGlyc
Page 74 and 75: Background - Footwear to Reduce Ulc
Page 76 and 77: period. In addition people without
Page 78 and 79: Comparisons of in-shoe foot pressur
Page 80 and 81: The rate of plantar callus formatio
Page 82 and 83: Evidence Table: Section 10AuthorFoo
Page 84 and 85: Background - Foot Clinics and Multi
Page 86 and 87: A prospective non randomised contro
Page 88 and 89: Summary - Foot Clinics and Multi-di
Page 90 and 91: Section 12: Diabetes Foot ProblemsI
Page 92 and 93: and/or osteomyelitis; III - fore-fo
Page 94 and 95: Summary - Economic consequences•
Page 96 and 97: Section 13: Diabetes Foot ProblemsI
Page 98 and 99: Some ethnic groups are associated w
Page 100 and 101: Evidence Table: Section 13AuthorSoc
Page 102 and 103: Calle-Pascual AL, Duran A, Diaz A,
Page 104 and 105: Jannink MJ, van Dijk H, de Vries J,
Page 106 and 107: Moss SE, Klein R, Klein BE. The 14-
Page 108 and 109: Soulier SM, Godsey C, Asay ED, Perr
Page 110 and 111: Diabetes Foot Problems: General Ref
Page 114 and 115: Diabetes Foot Problems: Other Refer
Page 116 and 117: Caputo GM, Cavanagh PR, Ulbrecht JS
Page 118 and 119: Garbalosa JC, Cavanagh PR, Wu G, Ul
Page 120 and 121: Lavery LA, Armstrong DG, Wunderlich
Page 122 and 123: Payne C. Regional variations of dia
Page 124 and 125: Tovi J, Svanborg E, Nilsson BY, Eng
Page 126 and 127: Criteria used to determine the suit
Page 128 and 129: QUESTIONS KEY WORDS NO.ARTICLESIDEN
show all

Part 6: Detection and Prevention of Foot Problems in Type 2 Diabetes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?